LONZA
Live / Registered — Registered (as of 21 Jan 2025)
What this means for you
Registered since 21 Jan 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79389966
- Registration number
- 7656626
- Mark type
- Word mark
- Filed
- 12 Oct 2023
- Published for opposition
- 03 Dec 2024
- Registered
- 21 Jan 2025
- Attorney of record
- Lawrence J. Crain
Goods and services
- Class 001 — Chemicals: Biological materials, namely, genetically modified cells for scientific and research use; biological tissue in the nature of genetic material and vectors, namely, cosmids, plasmids, viral material, or chromosomes for production of human, animal and synthetic proteins for scientific and pharmaceutical research; biological tissue, namely, human or animal blood, tissue and stem cells for use in scientific and pharmaceutical research; bioconjugates for scientific and pharmaceutical research; bioscience products, being biological tissue in the nature of primary cells, cell cultures and transfection compounds for life-science research; nutritional chemical compounds in bulk powder, tablet, capsule, gel, powder, and liquid form used in the manufacture of dietary and nutritional supplements or food additives; biological preparations, namely, genetically modified cells, genetic material and vectors in the nature of cosmids, plasmids, viral material, or chromosomes for the production of human, animal and synthetic proteins for commercial use, other than for medical or veterinary use; biological preparations for use in industry and science, namely, blood, tissue, blood cells and human or animal stem cells, for commercial use; biological preparations for use in industry and science, namely, bioconjugates for drug development; biological preparations for use in industry and science, namely, primary cells, cell cultures and transfection animal tissue for commercial use in human and animal therapies; biopharmaceutical chemicals, namely, monoclonal antibodies and proteins for scientific and pharmaceutical research
- Class 005 — Pharmaceuticals: Biological materials for medical and pharmaceutical use, namely, genetically modified cells, genetic material and vectors, namely, cosmids, plasmids, viral material, or chromosomes for production of human, animal and synthetic proteins for medical, clinical and commercial use; human or animal blood, tissue, blood cells and stem-cells for medical, clinical and commercial use; biopharmaceuticals, namely, antibodies and proteins for medical and pharmaceutical use; bioscience products, namely, primary cells, cell cultures and transfection products in the nature of human and animal cells for medical, clinical and commercial use in human and animal therapies; dietary and nutritional supplements; nutritional ingredients in the nature of nutritional supplements as components of dietary regimes and nutritional supplements for medical use in bulk, in the form of tablets, capsules, gel, powder, and liquid or as food additives
Owner
- Lonza Ltd., CH
- Lonza Ltd., CH
- Lonza Ltd., CH
Prosecution history
- 21 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 03 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Dec 2024 — PUBLISHED FOR OPPOSITION
- 27 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Sept 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Sept 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 Sept 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 Sept 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 Sept 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Sept 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Aug 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Aug 2024 — NON-FINAL ACTION E-MAILED
- 16 Aug 2024 — NON-FINAL ACTION WRITTEN